Abstract
Aerva lanata is a prostrate under-shrub used as traditional and modern system of medicine. The Prime of current study was to compare the antiproliferative and antioxidant potential of in vitro and in vivo leaf and callus extracts of Aerva lanata against human breast cancer (MCF 7) cell lines. Anticancer proficiency of methanol extracts of in vitro and in vivo leaf and matured callus extracts were evaluated by 3 - (4, 5 – dimethylthiazole – 2 – yl) - 2, 5 -diphenyl tetrazolium bromide (MTT) and DNA fragmentation assays. Earlier the total antioxidant potential of the different solvent extracts was tested by 2, 2' – azino – bis (3-ethylbenzthiazoline – 6 – sulphonic acid (ABTS) assay. A dose dependent inhibition of cancer cell proliferation was identified in MTT assay. Further, DNA fragmentation assay was performed and the results show the best IC50 values produced best possible digestion of DNA (by apoptosis). The results of radical scavenging activity of ABTS cation assay was recorded promising inhibitory effects of callus, in vivo and in vitro leaf methanol extracts. The inhibition rate was mainly dependent on concentration of extracts. Total phenols, tannins and flavonoids contents of the test samples were quantified. The overall results from the study highlights the use of least concentrations of methanolic callus extracts of plant has potential use in treatment of cancer related diseases in future.
Keywords: ABT’S, Aerva lanata, Callus, DNA fragmentation, MCF – 7, MTT.
The Natural Products Journal
Title:Antiproliferative and Antioxidant Potential of Leaf and Leaf Derived Callus Extracts of Aerva lanata (L.) Juss. Ex Schult. Against Human Breast Cancer (MCF-7) Cell Lines
Volume: 4 Issue: 4
Author(s): Deepak Kamalanathan and Devarajan Natarajan
Affiliation:
Keywords: ABT’S, Aerva lanata, Callus, DNA fragmentation, MCF – 7, MTT.
Abstract: Aerva lanata is a prostrate under-shrub used as traditional and modern system of medicine. The Prime of current study was to compare the antiproliferative and antioxidant potential of in vitro and in vivo leaf and callus extracts of Aerva lanata against human breast cancer (MCF 7) cell lines. Anticancer proficiency of methanol extracts of in vitro and in vivo leaf and matured callus extracts were evaluated by 3 - (4, 5 – dimethylthiazole – 2 – yl) - 2, 5 -diphenyl tetrazolium bromide (MTT) and DNA fragmentation assays. Earlier the total antioxidant potential of the different solvent extracts was tested by 2, 2' – azino – bis (3-ethylbenzthiazoline – 6 – sulphonic acid (ABTS) assay. A dose dependent inhibition of cancer cell proliferation was identified in MTT assay. Further, DNA fragmentation assay was performed and the results show the best IC50 values produced best possible digestion of DNA (by apoptosis). The results of radical scavenging activity of ABTS cation assay was recorded promising inhibitory effects of callus, in vivo and in vitro leaf methanol extracts. The inhibition rate was mainly dependent on concentration of extracts. Total phenols, tannins and flavonoids contents of the test samples were quantified. The overall results from the study highlights the use of least concentrations of methanolic callus extracts of plant has potential use in treatment of cancer related diseases in future.
Export Options
About this article
Cite this article as:
Kamalanathan Deepak and Natarajan Devarajan, Antiproliferative and Antioxidant Potential of Leaf and Leaf Derived Callus Extracts of Aerva lanata (L.) Juss. Ex Schult. Against Human Breast Cancer (MCF-7) Cell Lines, The Natural Products Journal 2014; 4 (4) . https://dx.doi.org/10.2174/2210315504666141119223215
DOI https://dx.doi.org/10.2174/2210315504666141119223215 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drug Interaction Potential of Trastuzumab Emtansine (T-DM1) Combined with Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer
Current Drug Metabolism Signaling Pathways Responsible for Cancer Cell Invasion as Targets for Cancer Therapy
Current Cancer Drug Targets Vitamin D: Evolutionary, Physiological and Health Perspectives
Current Drug Targets Molecular Imaging of Matrix Metalloproteinases In Vivo Using Small Molecule Inhibitors for SPECT and PET
Current Medicinal Chemistry Recent Advance in the Pharmacology of Dihydropyrimidinone
Mini-Reviews in Medicinal Chemistry The Therapeutic Potential of miR-7 in Cancers
Mini-Reviews in Medicinal Chemistry Recent Advances in the Design and Development of Anticancer Molecules based on PROTAC Technology
Current Medicinal Chemistry MiR-138 and MiR-135 Directly Target Focal Adhesion Kinase, Inhibit Cell Invasion, and Increase Sensitivity to Chemotherapy in Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Ligands and Therapeutic Perspectives of Adenosine A2A Receptors
Current Pharmaceutical Design Antiestrogenic Therapies in Solid Cancers and Multiple Myeloma
Current Molecular Medicine CEBP Epigenetic Dysregulation as a Drug Target for the Treatment of Hematologic and Gynecologic Malignancies
Current Drug Targets Phospholipase D Inhibition: Beneficial and Harmful Consequences for a Double-Dealer Enzyme
Current Enzyme Inhibition Editorial (Thematic Issue: Role of Drug Metabolism and its Mediated DDI in Drug Efficacy and Safety Part 2)
Current Drug Metabolism Syntheses and Biological Activities of triazole-based Sulfonamides
Current Organic Chemistry 19F: A Versatile Reporter for Non-Invasive Physiology and Pharmacology Using Magnetic Resonance
Current Medicinal Chemistry Anti-Tumor Mechanisms of Novel 3-(4-Substituted Benzyl)-5-Isopropil-5- Phenylhydantoin Derivatives in Human Colon Cancer Cell Line
Anti-Cancer Agents in Medicinal Chemistry Synthesis and Anticancer Properties of Methyl N1-(thien-4-yl)amidrazone- 3-carboxylates
Letters in Drug Design & Discovery Isolation and Characterization of a Lectin from Japanese Mottled Beans
Protein & Peptide Letters Reading and Writing the Blood-Brain Barrier: Relevance to Therapeutics
Recent Patents on CNS Drug Discovery (Discontinued) Non-Analgesic Effects of Opioids: Interactions Between Opioids and Other Drugs
Current Pharmaceutical Design